{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:03:47Z","timestamp":1781327027585,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T00:00:00Z","timestamp":1504569600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00277-017-3120-9","type":"journal-article","created":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T15:37:44Z","timestamp":1504625864000},"page":"1931-1936","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT)"],"prefix":"10.1007","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3793-1338","authenticated-orcid":false,"given":"D.","family":"Maira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cassinerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Marcon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mancarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fraquelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pedrotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. D.","family":"Cappellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,5]]},"reference":[{"key":"3120_CR1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2147\/JBM.S61540","volume":"7","author":"K Bayanzay","year":"2016","unstructured":"Bayanzay K, Alzoebie L (2016) Reducing the iron burden and improving survival in transfusion-dependent thalassemia patients: current perspectives. J Blood Med 7:159\u2013169","journal-title":"J Blood Med"},{"key":"3120_CR2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/nyas.13060","volume":"1368","author":"TD Coates","year":"2016","unstructured":"Coates TD, Carson S, Wood JC et al (2016) Management of iron overload in hemoglobinopathies: what is the appropriate target iron level? Ann N Y Acad Sci 1368:95\u2013106","journal-title":"Ann N Y Acad Sci"},{"key":"3120_CR3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/nyas.13088","volume":"1368","author":"JL Kwiatkowski","year":"2016","unstructured":"Kwiatkowski JL (2016) Current recommendations for chelation for transfusion-dependent thalassemia. Ann N Y Acad Sci 1368:107\u2013114","journal-title":"Ann N Y Acad Sci"},{"key":"3120_CR4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/nyas.13018","volume":"1368","author":"PR Oikonomidou","year":"2016","unstructured":"Oikonomidou PR, Casu C, Rivella S (2016) New strategies to target iron metabolism for the treatment of beta thalassemia. Ann N Y Acad Sci 1368:162\u2013168","journal-title":"Ann N Y Acad Sci"},{"key":"3120_CR5","first-page":"55","volume":"9","author":"A Ghavamzadeh","year":"2015","unstructured":"Ghavamzadeh A, Mirzania M, Kamalian N et al (2015) Hepatic iron overload and fibrosis in patients with beta thalassemia major after hematopoietic stem cell transplantation: a pilot study. Int J Hematol Oncol Stem Cell Res 9:55\u201359","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"3120_CR6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-230X-4-17","volume":"4","author":"FA Ardalan","year":"2004","unstructured":"Ardalan FA, Osquei MR, Toosi MN et al (2004) Synergic effect of chronic hepatitis C infection and beta thalassemia major with marked hepatic iron overload on liver fibrosis: a retrospective cross-sectional study. BMC Gastroenterol 4:17","journal-title":"BMC Gastroenterol"},{"key":"3120_CR7","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ajh.21752","volume":"85","author":"M Fraquelli","year":"2010","unstructured":"Fraquelli M, Cassinerio E, Roghi A et al (2010) Transient elastography in the assessment of liver fibrosis in adult thalassemia patients. Am J Hematol 85:564\u2013568","journal-title":"Am J Hematol"},{"key":"3120_CR8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ejrad.2013.08.038","volume":"82","author":"F Paparoa","year":"2013","unstructured":"Paparoa F, Cevascob L, Zefiroc D et al (2013) Diagnostic value of real-time elastography in the assessment ofhepatic fibrosis in patients with liver iron overload. Eur J Radiol 82:755\u2013761","journal-title":"Eur J Radiol"},{"key":"3120_CR9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0609.2007.01011.x","volume":"80","author":"T Mirault","year":"2008","unstructured":"Mirault T, Lucidarme D, Turlin B et al (2008) Non-invasive assessment of liver fibrosis by transient elastography in post transfusional iron overload. Eur J of Haematol 80:337\u2013340","journal-title":"Eur J of Haematol"},{"key":"3120_CR10","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.bbmt.2014.07.025","volume":"20","author":"A Hamidieh","year":"2014","unstructured":"Hamidieh A, Shazad B, Ostovaneh MR et al (2014) Noninvasive measurement of liver fibrosis using transient elastography in pediatric patients with major thalassemia who are candidates for hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20:1912\u20131917","journal-title":"Biol Blood Marrow Transplant"},{"key":"3120_CR11","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1365-2141.2009.07996.x","volume":"148","author":"V Marco Di","year":"2009","unstructured":"Di Marco V, Bronte F, Cabibi D et al (2009) Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE)\u2014lack of interference by iron deposition. Br J Haematol 148:476\u2013479","journal-title":"Br J Haematol"},{"key":"3120_CR12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bcmd.2012.06.001","volume":"49","author":"KM Musallam","year":"2012","unstructured":"Musallam KM, Motta I, Salvatori M et al (2012) Longitudinal changes in serum ferritin levels correlate with measures of hepatic stiffness in transfusion-independent patients with \u03b2-thalassemia intermedia. Blood Cells Mol Dis 49:136\u2013139","journal-title":"Blood Cells Mol Dis"},{"key":"3120_CR13","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/hepr.12088","volume":"43","author":"H Poustchi","year":"2013","unstructured":"Poustchi H, Eslami M, Ostovaneh MR et al (2013) Transient elastography in hepatitis C virus-infected patients with beta-thalassemia for assessment of fibrosis. Hepatol Res 43:1276\u20131283","journal-title":"Hepatol Res"},{"key":"3120_CR14","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2004-10-3982","volume":"106","author":"JC Wood","year":"2005","unstructured":"Wood JC, Enriquez C, Ghugre N et al (2005) MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle-cells disease patients. Blood 106:1460\u20131465","journal-title":"Blood"},{"issue":"2","key":"3120_CR15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13244-011-0132-1","volume":"3","author":"JM Al\u00fastiza Echeverr\u00eda","year":"2012","unstructured":"Al\u00fastiza Echeverr\u00eda JM, Castiella A, Emparanza JI (2012) Quantification of iron concentration in the liver by MRI. Insights Imaging 3(2):173\u2013180","journal-title":"Insights Imaging"},{"key":"3120_CR16","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1148\/radiol.2015150619","volume":"276","author":"RG Barr","year":"2015","unstructured":"Barr RG, Ferraioli G, Palmeri ML et al (2015) Elastography assessment of liver fibrosis: society of radiologists in ultrasound consensus conference statement. Radiology 276:845\u2013861","journal-title":"Radiology"},{"key":"3120_CR17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF02662506","volume":"6","author":"SI Mavrogeni","year":"1998","unstructured":"Mavrogeni SI, Gotsis ED, Markussis V et al (1998) T2 relaxation time study of iron overload in b-thalassemia. MAGMA 6:7\u201312","journal-title":"MAGMA"},{"key":"3120_CR18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood.V100.1.17","volume":"100","author":"E Angelucci","year":"2002","unstructured":"Angelucci E, Muretto P, Nicolucci A et al (2002) Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood 100:17\u201321","journal-title":"Blood"},{"key":"3120_CR19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/bjh.13009","volume":"167","author":"C Borgna-Pignatti","year":"2014","unstructured":"Borgna-Pignatti C, Garani MC, Forni GL et al (2014) Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry. Br J Haematol 167:121\u2013126","journal-title":"Br J Haematol"},{"key":"3120_CR20","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2141.2010.08346.x","volume":"151","author":"V Ladis","year":"2010","unstructured":"Ladis V, Berdousi H, Gotsis E et al (2010) Deferasirox administration for the treatment of non-transfusional iron overload in patients with thalassaemia intermedia. Br J Haematol 151:504\u2013508","journal-title":"Br J Haematol"},{"key":"3120_CR21","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/j.gastro.2011.06.065","volume":"141","author":"Y Deugneir","year":"2011","unstructured":"Deugneir Y, Turlin B, Ropert M et al (2011) Improvement in liver pathology of patients with \u03b2-thalassemia treated with deferasirox for at least 3 years. Gastroenterology 141:1202\u20131211","journal-title":"Gastroenterology"},{"key":"3120_CR22","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/1440-1681.12591","volume":"43","author":"A Mohammed","year":"2016","unstructured":"Mohammed A, Abd Al Haleem EN, El-Bakly WM et al (2016) Deferoxamine alleviates liver fibrosis induced by CCl4 in rats. Clin Exp Pharmacol Physiol 43:760\u2013768","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"3120_CR23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bcp.2015.09.001","volume":"98","author":"SF Darwish","year":"2015","unstructured":"Darwish SF, El-Bakly WM, El-Naga RN et al (2015) Antifibrotic mechanism of deferoxamine in concanavalin A induced-liver fibrosis: impact on interferon therapy. Biochem Pharmacol 98:231\u2013242","journal-title":"Biochem Pharmacol"},{"key":"3120_CR24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/03630260600642534","volume":"30","author":"SF Wu","year":"2006","unstructured":"Wu SF, Peng CT, Wu KH et al (2006) Liver fibrosis and iron levels during long-term deferiprone treatment of thalassemia major patients. Hemoglobin 30:215\u2013218","journal-title":"Hemoglobin"},{"key":"3120_CR25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/03630260600642518","volume":"30","author":"AC Chen","year":"2006","unstructured":"Chen AC, Peng CT, Wu SF et al (2006) Effect of deferiprone on liver iron overload and fibrosis in hepatitis-C-virus-infected thalassemia. Hemoglobin 30:209\u2013214","journal-title":"Hemoglobin"},{"key":"3120_CR26","doi-asserted-by":"crossref","first-page":"785","DOI":"10.26719\/2009.15.4.785","volume":"15","author":"MJ Saffar","year":"2009","unstructured":"Saffar MJ, Saffar H, Khalilian AR et al (2009) Combination therapy with interferon and ribavirin for chronic hepatitis C infection in beta-thalassaemia major. East Mediterr Health J 15:785\u2013791","journal-title":"East Mediterr Health J"},{"key":"3120_CR27","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3324\/haematol.12352","volume":"93","author":"P Harmatz","year":"2008","unstructured":"Harmatz P, Jonas MM, Kwiatkowski JL et al (2008) Safety and efficacy of pegylated interferon \u0391-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia. Haematologica 93:1247\u20131251","journal-title":"Haematologica"},{"key":"3120_CR28","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3324\/haematol.13500","volume":"93","author":"E Angelucci","year":"2008","unstructured":"Angelucci E, Pilo F (2008) Treatment of hepatitis C in patients with thalassemia. Haematologica 93:1121\u20131123","journal-title":"Haematologica"},{"key":"3120_CR29","first-page":"1204","volume":"97","author":"S Fargion","year":"2002","unstructured":"Fargion S, Fracanzani AL, Rossini A et al (2002) Iron reduction and sustained response to interferon therapy in patients with chronic hepatitis C: results of an italian multicenter randomized study. Am J Gastroenterol 97:1204\u20131210","journal-title":"Am J Gastroenterol"},{"key":"3120_CR30","first-page":"4","volume":"12","author":"FA Ardalan","year":"2004","unstructured":"Ardalan FA, Osquei MR, Toosi MN et al (2004) Synergic effect of chronic hepatitis C infection and beta thalassemia major with marked hepatic iron overload on liver fibrosis: a retropspective cross-sectional study. BMC Gastroenterol 12:4\u201317","journal-title":"BMC Gastroenterol"},{"key":"3120_CR31","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3324\/haematol.12554","volume":"93","author":"V Marco Di","year":"2008","unstructured":"Di Marco V, Capra M, Gagliardotto F et al (2008) Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. Haematologica 93:1243\u20131246","journal-title":"Haematologica"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-017-3120-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3120-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3120-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:47:46Z","timestamp":1570063666000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-017-3120-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,5]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["3120"],"URL":"https:\/\/doi.org\/10.1007\/s00277-017-3120-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,5]]}}}